Maravai LifeSciences Holdings (MEX:MRVI) Long-Term Debt: MXN4,248 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MRVI Maravai LifeSciences Holdings Inc MEX:MRVI
56 GF Score
Price MXN85.00
GF Value MXN44.85
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Long-Term Debt?

Maravai LifeSciences Holdings MEX:MRVI 56 Long-Term Debt is MXN4,248 Mil as of Mar. 2026. GuruFocus rates MEX:MRVI with a GF Score™ of 56/100 and a GF Value™ of MXN44.85. The stock has 8 warning signs investors should review.

Maravai LifeSciences Holdings's Long-Term Debt for the quarter that ended in Mar. 2026 was MXN4,248 Mil.

Maravai LifeSciences Holdings's quarterly Long-Term Debt declined from Sep. 2025 (MXN5,272 Mil) to Dec. 2025 (MXN5,156 Mil) and declined from Dec. 2025 (MXN5,156 Mil) to Mar. 2026 (MXN4,248 Mil).

Maravai LifeSciences Holdings's annual Long-Term Debt declined from Dec. 2023 (MXN8,805 Mil) to Dec. 2024 (MXN6,058 Mil) and declined from Dec. 2024 (MXN6,058 Mil) to Dec. 2025 (MXN5,156 Mil).

Maravai LifeSciences Holdings  (MEX:MRVI) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Maravai LifeSciences Holdings Long-Term Debt Related Terms

Maravai LifeSciences Holdings Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Maravai LifeSciences Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maravai LifeSciences Holdings Long-Term Debt Chart

Maravai LifeSciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 10,761.46 10,176.85 8,804.66 6,058.41 5,155.59

Maravai LifeSciences Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,922.63 5,431.02 5,271.78 5,155.59 4,247.98
MEX:MRVI
56GF Score
Maravai LifeSciences Holdings Inc MEX:MRVI
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of MXN4,248 Mil mean?
Maravai LifeSciences Holdings (MEX:MRVI) has a Long-Term Debt of MXN4,248 Mil as of Mar. 2026.
Is Maravai LifeSciences Holdings' Long-Term Debt too high?
Maravai LifeSciences Holdings' current Long-Term Debt is MXN4,248 Mil. Overall, Maravai LifeSciences Holdings has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' Long-Term Debt compare to LBRX and SLDB?
Maravai LifeSciences Holdings' Long-Term Debt of MXN4,248 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Maravai LifeSciences Holdings's current Long-Term Debt is MXN4,248 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current Long-Term Debt of MXN4,248 Mil. The stock's GF Value™ is MXN44.85, compared to a current price of MXN85.00 — trading 89.5% above its estimated fair value. The current Long-Term Debt is MXN4,248 Mil. Maravai LifeSciences Holdings' overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current Long-Term Debt is MXN4,248 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of MXN85.00 is trading 89.5% above its estimated GF Value™ of MXN44.85.

Key valuation signals for MEX:MRVI:

  • Long-Term Debt: MXN4,248 Mil
  • GF Value™: MXN44.85 vs. price of MXN85.00 (89.5% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USAMAR:Germany
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
56GF Score

Get the complete analysis for MEX:MRVI

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN85.00
Price
MXN44.85
GF Value